Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach | MicrobiomeTrials← Back to trialsNCT04685200
Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
RecruitingOBSERVATIONAL
Trial Details
Start: 2023-03-31Est. Completion: 2026-10-31
Enrollment target: 143 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Primary Sclerosing Cholangitis
This study is a clinical trial being done to investigate the efficacy of drug BRS201 (hydroxocobalamin) as a treatment i…
Chestnut Hill, United StatesEst. completion May 1, 2027
Primary Sclerosing CholangitisLiver Transplant, ComplicationsPSCBiliary Strictures
This study aims to determine the efficacy of 36 months once-daily fenofibrate in preventing clinically-detectable recurr…
Scottsdale, United StatesEst. completion Mar 30, 2028